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Abstract
Background: To study mortality rate and causes of death among all hospitalized opioid addicts
treated for self-poisoning or admitted for voluntary detoxification in Oslo between 1980 and 1981,
and to compare their mortality to that of the general population.
Methods: A prospective cohort study was conducted on 185 opioid addicts from all medical
departments in Oslo who were treated for either self-poisoning (n  = 93, 1980), voluntary
detoxification (n = 75, 1980/1981) or both (n = 17). Their median age was 24 years; with a range
from 16 to 41, and 53% were males. All deaths that had occurred by the end of 2000 were identified
from the Central Population Register. Causes of death were obtained from Statistics Norway.
Standardized mortality ratios (SMRs) were computed for mortality, in general, and in particular, for
different causes of death.
Results: During a period of 20 years, 70 opioid addicts died (37.8%), with a standardized mortality
ratio (SMR) equal to 23.6 (95% CI, 18.7–29.9). The SMR remained high during the whole period,
ranging from 32.4 in the first five-year period, to 13.4 in the last five-year period. There were no
significant differences in SMR between self-poisonings and those admitted for voluntarily
detoxification. The registered causes of death were accidents (11.4%), suicide (7.1%), cancer
(4.3%), cardiovascular disease (2.9%), other violent deaths (2.9%), other diseases (71.4%). Among
the 50 deaths classified as other diseases, the category "drug dependence" was listed in the vast
majority of cases (37 deaths, 52.9% of the total). SMRs increased significantly for all causes of death,
with the other diseases group having the highest SMR; 65.8 (95% CI, 49.9–86.9). The SMR was 5.4
(95% CI, 1.3–21.5) for cardiovascular diseases, and 4.3 (95% CI, 1.4–13.5) for cancer. The SMR was
13.2 (95% CI, 6.6–26.4) for accidents, 10.7 (95% CI, 4.5–25.8) for suicides, and 28.6 (95% CI, 7.1–
114.4) for other violent deaths.
Conclusion: The risk of death among opioid addicts was significantly higher for all causes of death
compared with the general population, implying a poor prognosis over a 20-year period for this
young patient group.
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Background
Mortality rates among opioid addicts are higher than for
the general population, although there are differences
between countries and regions [1]. Standardized mortality
ratios (SMRs) vary between 15 and 28 in different studies
[2-4]. In spite of the increased mortality, and hence the
need for intervention, Cook et al. found that 67% of
patients who attended an emergency department because
of acute opioid overdose were not referred to any thera-
peutic programme for drug addiction [5]. During the last
few decades, studies have focused on abstinence versus
continued drug use following participation in various
treatment programmes, as an outcome measure [6], even
though there is still some doubt about whether such pro-
grammes have a long-term effect on mortality. In a 15-
year follow-up study, Sorensen et al. found that people
who had achieved stable abstinence from injectable nar-
cotics use were at lower risk of premature death when
compared with those who continued using drugs [7].
However, even in the presumed abstinence group, there
was a sevenfold increase in SMR. This raises the question
whether referral to a detoxification programme has a sat-
isfactory effect on long-term mortality.
Although the majority of deaths among opioid addicts are
from accidental poisonings [8], deaths from other unnat-
ural causes, such as suicide, have also increased [9,10].
The co-morbidity between drug dependence and suicide
has been described both as an association between drug
dependence and mental illness [11], and between known
risk factors for both drug dependence and suicide, such as
gender, living alone and unemployment [12]. In an
empirical review, Wilcox et al. estimated the SMR for sui-
cide associated with opioid dependence, but did not esti-
mate SMRs for other diseases [10]. In another empirical
review, Harris and Barraclough calculated SMRs for both
natural and unnatural causes of death associated with opi-
oid dependence [13].
Review studies, which have proven useful in pointing out
the increased mortality in this patient group, have used
expected number of deaths based on WHO data, rather
than patient data. The analyses in Harris and Barra-
clough's review were based on 10 papers with a follow-up
period ranging from 1 to 28 years, and the SMRs for natu-
ral causes of death were based on only one study. Longer
prospective follow-up studies of opioid addicts show how
the overall mortality rate changes over time [14], it being
expected that cause-specific mortality would also differ
between long-term and short-term follow-up studies.
Although cause-specific mortality rates were measured in
one four-year prospective cohort study, no SMRs were
obtained [15]. Prospective cohort studies in the field are
relatively uncommon [15], and even rarer is the opportu-
nity to compare the cohort with a well-defined back-
ground population that includes a whole city. However,
long-term prospective studies of excess mortality among
opioid addicts, in particular, would be useful for obtain-
ing more specific information about opioid addictions as
a subgroup of substance use disorders.
During recent decades, the AIDS epidemic has had a
major effect on this group of patients [16]. Although mor-
tality among opioid addicts increased from 1980 to 1988
[17], this increase can only be partly explained by the
emergence of AIDS [18]. Cause-specific SMRs during
recent decades would be helpful in studying mortality in
this group of patients.
The aims of this study were to study the mortality rate and
causes of death among opioid addicts who had been
treated for self-poisoning or admitted to voluntary detoxi-
fication in 1980 and 1981 during a 20-year follow-up
investigation. The study compared this cohort with the
general population. The study's design allowed an investi-
gation of whether participation in a detoxification pro-
gramme can be protective.
Methods
Participants
The study included all opioid addicts hospitalized due to
self-poisoning in Oslo in 1980, as well as all opioid
addicts admitted for voluntary detoxification in 1980 and
1981 (Table 1). All patients who were discharged follow-
ing treatment for self-poisoning and classified as opioid
abusers in 1980 in Oslo (454,000 inhabitants) medical
departments, were included. This subgroup was obtained
from a larger prospective cohort study that included all
patients treated for self-poisoning in Oslo medical depart-
ments in 1980 [19,20]. Patients leaving directly from the
emergency room after treatment were also included in the
study. The first, or the most serious, admission (i.e.,
Table 1: Opioid addicts treated at medical departments in Oslo in 1980/1981
Self-poisonings n = 93 Voluntary detoxification n = 92 Total n = 185
Females 32 54 86 (46.5%)
Males 61 38 99 (53.5%)
Median age 24 23 24
Average number of admittances 1.4 1.4 1.4BMC Psychiatry 2008, 8:8 http://www.biomedcentral.com/1471-244X/8/8
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according to the toxic agent used and the amount taken)
was chosen as the index episode.
All opioid addicts admitted to Ullevaal University Hospi-
tal for voluntary detoxification during 1980 and 1981
were included in the study. During the late 1970s, the
number of opioid addicts increased rapidly in Oslo, par-
ticularly among young people. The treatment facilities
were rather poor. Therefore, from 1980, the Department
of Acute Medicine (previously Medical Department 7)
accepted the responsibility for treating up to three opioid
addicts simultaneously. These people were in need of
detoxification, either before further treatment in drug
addiction units, or due to their poor overall health, Ulle-
vaal University Hospital serving this function for the
whole city [21]. Before admittance, volunteer patients
were interviewed to obtain their agreement regarding the
ward's rules, and they were informed that no opioids or
benzodiazepines would be prescribed. They were offered
neuroleptics and medication, such as alimemazin, which
served as hypnotics. Their health contact person was usu-
ally present on admission. They had daily meetings with a
social worker or a psychiatrist for support and planning
further treatment. The staff at the units received regular
supervision. About 75% of those patients who were
detoxified were transferred for further planned treatment
programmes. About 50% of those in a bad physical con-
dition, left the unit before they were advised to do so. The
average length of stay for the total group was 3.5 days.
Although patients who had experienced an opioid drug
overdose were offered interviews with a social worker or a
psychiatrist, most of them were not interested in further
treatment and left the hospital when they were able to do
so.
The present cohort contained 185 opioid addicts treated
for either self-poisoning (n = 93), voluntary detoxification
(n = 75), or both (n = 17). Those who were admitted ini-
tially for self-poisoning and later for detoxification were
classified in further analyses as voluntarily detoxifica-
tions, to indicate their willingness to undergo further
treatment and rehabilitation. Some patients were hospi-
talized several times (Table 2). Since information about
the status of the patients at discharge was only available
for groups and not individuals, the statistical significance
of this variable was not investigated. There were 99
(53.5%) males and 86 (46.5%) females. Their median age
was 24 years (range 16–41), 72% of patients being in the
20–29 year age group (n = 133).
Design
Classification of abuse was based on patient interviews
and records. The basic criteria were information about
daily, or regular, use of the respective compounds, includ-
ing withdrawal symptoms if the compounds were not
administered.
The causes of death were classified according to the death
certificates provided by Statistics Norway and grouped
according to the appropriate standards. Thus, the same
classification was used for both the study population and
the general population. Death certificates were based on
forensic autopsy records for all cases that did not involve
natural causes [22]. Appropriate categories from the Inter-
national Classification of Diseases (ICD) were used for
deaths occurring before 1987 (ICD-8), for deaths from
1987 to 1996 (ICD-9), and for deaths from 1996 to 2000
(ICD-10). All deaths were categorized according to their
major cause: cardiovascular disease, cancer, other dis-
eases, suicide, accidents, and other violent deaths. The cat-
egory, other diseases, consisted of all diseases except for
cardiovascular diseases and cancer. Other violent deaths
consisted of all external causes of injury, except for sui-
cides and accidents. There was no specific cause of death
for four patients, three deaths being recorded as 799
unknown (ICD-9), and one being recorded as R999
unknown (ICD-10). These cases were all classified as
other diseases.
Mortality in the cohort was compared with that of the gen-
eral population of Norway. Reference rates were com-
puted in terms of five-year calendar periods and five-year
age groups (15–19, 20–24, etc.) for each gender. Patients
were followed to emigration, death or the end of 2000,
whichever occurred first. Dates of emigration and death
were obtained from the Central Population Registry. Per-
son-time under observation, categorized by five-year cal-
endar periods and five-year age groups (15–19, 20–24,
etc.), was obtained for each gender. Mortality rates in the
general population for the same cross-classification served
as reference rates. The expected number of deaths was
computed by multiplying the observed person-time in the
cohort by the reference rates for each cell in the cross-clas-
sification, and appropriately adding the results. SMRs
were computed by taking the ratio of observed to expected
deaths (i.e., the ratio of the number of deaths observed in
the study group to the number of deaths that would be
Table 2: Number of self-poisonings and voluntary detoxifications 
among the cohort of opioid addicts during 1980/1981
Group n %
1 self-poisoning 71 38.4
> 1 self-poisoning 22 11.9
self-poisoning and voluntary detoxification 17 9.2
1 voluntary detoxification 58 31.4
> 1 voluntary detoxification 17 9.2
Total 185 100.1BMC Psychiatry 2008, 8:8 http://www.biomedcentral.com/1471-244X/8/8
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expected if the study population had the same specific
rates as the standard population).
Data analyses
The 95% confidence interval (95% CI) was computed for
each SMR, based on the assumption that observed deaths
follow a Poisson distribution. Stata release 8.0 pro-
grammes were used for survival analysis (Stata Corpora-
tion). For other data analyses, SPSS version 14.0 was used
(SPSS Inc.). Comparisons between groups were per-
formed using chi-squared tests, P < 0.05 being considered
statistically significant.
Ethics
Permission for both the original cohort study and the fol-
low-up study was obtained from the National Data
Inspectorate and the Regional Ethics Committee, both of
which agreeing that informed consent was not necessary.
Asking the patients' permission in advance to check
whether they had committed suicide or had died from
other causes during a 20-year follow-up period was con-
sidered unethical. All data were stored anonymously by
substituting a number code for each patient's name, and
placing the data in the locked office of the head physician.
Results
Mortality rates
During the 20-year follow-up period, 70 of the patients
died (37.8%), including 23 females (31.4%) and 47
males (48.5%). Five patients (2.7%) had emigrated, and
110 patients (59.5%) were still alive. The overall SMR was
23.6 (95% CI, 18.7–29.6). The SMR was 23.4 (95% CI,
17.6–31.1) for males, and 24.2 (95% CI, 16.1–36.4) for
females, this difference between males and females being
non-significant. SMR was increased in each successive
five-year period following the initial self-poisoning (Table
3), the highest SMR occurring in the first five years, 32.4
(95% CI, 21.3–49.1). The median age at death was 34
years, with a range from 20 to 58.
Differences between patients treated for self-poisoning 
and those treated voluntarily for detoxification
Forty patients (43.0%) died among those solely dis-
charged after self-poisonings, and 30 patients (48.4%)
died among those treated voluntarily for detoxification
(Table 3). The SMR was 23.5 (95% CI, 17.2–32.0) for
those discharged after an episode of self-poisoning,
whereas the SMR was 23.8 (95% CI, 16.6–34.0) for those
who were admitted voluntarily for detoxification. The dif-
ference in SMR between groups was not statistically signif-
icant, nor were there any significant gender differences.
For both groups, mortality was highest during the first five
years after admittance, and remained high during the
whole period thereafter.
Causes of death
The main causes of death were categorized as accidents (n
= 8, 11.4%), suicide (n = 5, 7.1%), cancer (n = 3, 4.3%),
other violent deaths (n = 2, 2.9%), cardiovascular disease
(n = 2, 2.9%), and other diseases (n = 50, 71.4%). The
other diseases category compromised the vast majority of
deaths. In 37 cases (52.9% of the total), the cause of death
was classified in ICD-8 and ICD-9 as category 304, Drug
dependence (Table 4), and listed according to ICD-9 as a
natural cause of death.
SMRs were significantly increased for all causes of death
(Table 5). The other diseases category had the highest
SMR, 65.8 (95% CI, 49.9–86.9). Accidental poisonings,
that is overdoses, were included in the accidents category,
with an SMR equal to 13.2 (95% CI, 6.6–26.4). There
were five suicides among the deaths, the SMR for suicide
being 10.7 (95% CI, 4.5–25.8).
HIV/AIDS caused one death among the patients in this
study (Table 4), and three deaths that occurred in 1990,
1992 and 1994 were classified as immune system disor-
ders. Additional causes of death were bronchopneumo-
nia, Hodgkin's disease and unspecified infectious or
parasitic disease.
Table 3: Deaths and standardized mortality ratios (SMRs) for opioid addicts for each five-year period
Self-poisonings Voluntary detoxification Total
Deaths SMR (95% CI) Deaths SMR (95% CI) Deaths SMR (95% CI)
Period 1 12 28.8 (16.3–50.7) 10 38.0 (20.5–70.7) 22 32.4 (21.3–49.1)
Period 2 11 28.2 (15.6–51.0) 9 31.1 (16.2–59.7) 20 29.5 (19.0–45.7)
Period 3 11 27.5 (15.5–49.7) 5 16.0 (6.7–38.4) 16 22.5 (13.8–36.7)
Period 4 6 12.1 (5.4–26.9) 6 15.1 (7.0–33.7) 12 13.4 (7.6–23.7)
Total 40 23.5 (17.2–32.0) 30 23.8 (16.6–40.0) 70 23.6 (18.7–29.9)BMC Psychiatry 2008, 8:8 http://www.biomedcentral.com/1471-244X/8/8
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For the 37 deaths classified as drug dependence, an addi-
tional cause of death was mainly category 965, poisoning
by analgesics, antipyretics and antirheumatics (ICD-9)
accounting for 28 of the cases. For the rest of the group,
acute or subacute endocarditis, unspecified bronchopneu-
monia, accidental poisoning by alcohol, accidental poi-
soning by barbiturates, and poisoning by other
unspecified drugs or medicinal substances were listed.
In ICD-10, the drug dependence category per se does not
exist. However, one death was classified as F11.0, psychi-
atric diseases and behavioural diseases caused by opiate
dependence, and Hepatitis C and HIV were stated as addi-
tional causes of death. One death was classified as F19.0,
psychiatric diseases and behavioural diseases caused by
multiple drug dependence, with no additional cause of
death listed. One death was classified as F12.0, mental
and behavioural disorders due to use of cannabinoids,
whereas chronic viral hepatitis B was an additional cause
of death.
The numbers of deaths in each five-year period were too
small to obtain cause-specific SMRs. However, causes of
death were distributed evenly throughout the study
period.
Discussion
This prospective study followed all hospital-treated opi-
oid addicts from the same large city, up to as long as 20
years. All patients were traced during this period, thus
minimizing selection bias. Causes of death were obtained
for all patients, enabling cause-specific mortality ratios to
be determined so that they could be compared with those
of the general population.
This study's main finding was the high mortality rate of
37.8%. One-third of females and almost half of males
died. This high mortality rate was observed in a young
patient group, for which the median age during 1980 and
1981 was 24 years. When corrected for the expected
number versus the observed number of deaths, SMRs
showed no statistically significant gender differences.
Although in absolute numbers males had a higher mortal-
ity ratio than females, the expected number of deaths
among males was higher as well. Therefore, the SMRs for
males and females were almost identical, there being a 23-
fold increase in mortality. In this study, the effect of opi-
oid addiction seemed to overrule the effects of age and
gender on mortality.
The SMR of 23.6, found for this cohort, is similar to SMRs
obtained in other long-term European studies [1],
although there were differences in the inclusion criteria
for these studies. SMRs were 15 times higher for male drug
Table 4: Deaths during follow-up that were classified as other diseases. The deaths are further specified according to the ICD systems.
Code Title n %
304 Drug dependence 37 74.0
305 Non-dependent abuse of drugs 24 . 0
279 Disorders involving the immune mechanism 3 6.0
B20.1 HIV 12 . 0
F11.0 Psychiatric diseases and behavioural diseases caused by opiate dependence 1 2.0
F12.0 Mental and behavioural disorders due to use of cannabinoids 1 2.0
F19.0 Psychiatric diseases and behavioural diseases caused by multiple drug dependence 1 2.0
799 Unknown 36 . 0
R999 Unknown 12 . 0
Total 50 100
Table 5: Causes of death during a 20-year follow-up of opioid addicts
Cause of death Females SMR (95% CI) Males SMR (95% CI) Total SMR (95% CI)
Cardiovascular disease 0 - 2 7.1 (1.8–28.4) 2 5.4 (1.3–21.5)
Cancer 2 5.1 (1.3–20.5) 1 3.3 (0.5–23.6) 3 4.3 (1.4–13.5)
Other diseases 15 63.8 (38.5–105.9) 35 66.7 (47.9–92.9) 50 65.8 (49.9–86.9)
Accidents 2 20.8 (5.2–83.2) 6 11.8 (5.3–26.2) 8 13.2 (6.6–26.4)
Suicide 3 25.9(8.3–80.2) 2 5.7 (1.4–22.9) 5 10.7 (4.5–25.8)
Other violent deaths 1 43.2 (6.1–306.7) 1 21.4 (3.0–151.8) 2 28.6(7.16–114.4)
Total 23 24.2 (16.1–36.4) 47 23.4 (17.6–31.1) 70 23.6 (18.7–29.9)BMC Psychiatry 2008, 8:8 http://www.biomedcentral.com/1471-244X/8/8
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users in Rome compared with the general population [2],
22 times higher for drug injectors in Glasgow [3], and
28.5 times higher for heroin addicts in Catalonia, Spain
[4].
The lack of gender differences has also been observed in
other studies, such as those conducted with homeless peo-
ple who had a drug addiction [23]. However, other studies
have found higher SMRs for either males [8,15] or females
[2,13]. This diversity of findings may be due to different
inclusion criteria. Gender differences have been observed
when notified addicts or drug users, who were recruited
from drug treatment centres, were included whereas the
present study included hospital-treated opioid addicts.
Therefore, this subject sample may have been more prone
to accidental poisoning, such incidents being less corre-
lated to gender perhaps than to behavioural traits, such as
the pattern of drug use. Irrespective of toxic compound,
the SMR for hospital-treated opioid addicts was much
higher than that for hospital-treated self-poisonings. In a
20-year follow-up study of all self-poisonings treated in
Oslo hospitals in 1980, the SMR was 4.6 (95% CI, 4.1–
5.1), compared with 23.6 in the present cohort [24]. Opi-
oid addicts are therefore at special risk. There were a
higher number of deaths in the first five-year period of the
study, and a decrease in SMR from 32.4 in the first five-
year period to 13.4 in the last five-year period. It is sug-
gested that those who take the highest risks will probably
die early, leading to a decrease in mortality for the cohort
as a whole. It has been shown that the number of active
drug addicts declines mainly from death, rather than from
long-term abstinence [25]. The decrease in SMR may also
be due partly to increased mortality in the general popu-
lation over time, leading to a relative reduction in the
ratio.
There was an increased mortality for all causes of death
among opioid addicts when compared with the general
population, including both natural and unnatural causes
of death. This was consistent with what is known about
substance abusers in general [13]. The causes of death
were mainly drug-related, as has been observed in other
studies [3,15]. Five suicides occurred in the cohort. The
increased risk of suicide among opioid addicts accords
with other studies [9,10]. There has been controversy
about the possible existence of a substantial number of
hidden suicides among accidental poisonings. So far, the
results support the hypothesis that most deliberate poi-
sonings are accidental [26,27]. In the present study, the
causes of death were obtained from Statistics Norway, and
our group reported on the validity of these data in 1985
[28]. Since then, autopsy rates have been declining in Nor-
way, and the reliability of death certificates has been ques-
tioned [29]. Therefore, the suicide numbers may well be
too low. Mortality in the study population was compared
with mortality rates from the whole country. Although the
expected lifespan is lower in Oslo than the average for the
country as a whole, it is less than one year below the aver-
age. Although SMR values found in the current study may
be somewhat high, this will not change the study's major
findings.
Only five deaths were registered as specific natural causes
of death, three being cancer and two being cardiovascular
diseases. The SMRs increased significantly, possibly due to
confounding factors such as lower socio-economic status
or tobacco use. Nevertheless, opioid addicts represent a
group that is at high risk for excess mortality, not only
from drug-related deaths, but also because of their
increased risk of death from cancer and cardiovascular dis-
eases. The increased risk of death, even from natural
causes, is consistent with the increased mortality associ-
ated with other mental disorders [13].
Only one death could be classified as being caused by
AIDS, although three deaths were stated as "disorders
involving the immune mechanism". In other studies,
AIDS has accounted for a majority of the deaths among
opioid addicts [4]. A study of HIV-positive opioid addicts
in Oslo found that drug overdose was a major cause of
death, thus overriding the effect of AIDS on mortality
[30].
The major cause of death was drug dependence, as regis-
tered in the other diseases category. In order to compare
this cohort with the general population, we used the same
categories as Statistics Norway. Although the SMR for this
single cause of death was not calculated, this value would
have provided minimal additional information. If drug
dependence is a chronic disease, a symptom of which is
opioid addiction, one would expect that only those suffer-
ing from the disease would die from it; that is, there would
be a low number of deaths in the background population.
Even when all other diseases were considered in the gen-
eral population, death from drug dependence outnum-
bers the total number of deaths from all other diseases. As
the classification of drug-related deaths is problematic in
the ICD system, the term "drug-related deaths", used in
mortality statistics, is currently being developed by the
European Monitoring Centre for Drugs and Drug Addic-
tion.
The category, drug dependence, is not equivalent literally
to any category in ICD-10. Chapter X4 can be used for
accidental poisonings, whereas F10 to F19 cover psychiat-
ric and behavioural disorders caused by drug dependence.
The incongruence of these classification systems makes it
difficult to know if the categories cover the same spectrum
of patients.BMC Psychiatry 2008, 8:8 http://www.biomedcentral.com/1471-244X/8/8
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In this study, mortality did not change from referral to
voluntarily detoxification. Our hypothesis was that those
treated solely for self-poisonings would have a poorer
prognosis, since such people were not sent to drug addic-
tion units on a regular basis. Sorensen et al. found a sig-
nificant decrease in mortality for those who achieved
abstinence [7], but in the present study, it was not known
whether patients completed or discontinued the detoxifi-
cation programme. Those who joined the programme vol-
untarily may have also been in a poorer physical
condition, since this was one of the criteria for admit-
tance. Some of the patients admitted for detoxification
were transferred to other units specialising in the treat-
ment of addicts, whereas others were admitted for a few
days of detoxification in the medical department because
of their extremely poor medical and physical state. Gener-
ally, these patients were not motivated to partake in treat-
ment required to achieve abstinence, and were among
those with the most serious drug addiction problems. In
addition, we did not have information about the comple-
tion rate for those transferred for further treatment.
Unfortunately, in retrospect, we were unable to trace the
status of each patient at discharge, but could only do so
for the group as a whole. However, the high level of mor-
tality in both subgroups supports the hypothesis that
referral to a detoxification programme alone is not suffi-
ciently effective to prevent the excess mortality for this
group. Patients probably need a longer and more closely
supervised follow-up, both to improve their physical
health and to achieve abstinence.
Since the relatively small numbers of deaths in each cate-
gory did not make it meaningful to obtain cause-specific
SMRs for each time period, it was not possible to investi-
gate how cause-specific mortality ratios change over time.
Subgroups might have been used in the statistical analyses
to evaluate the effect of repeated treatments on mortality.
However, the resulting groups would be too small to
reveal any statistically significant differences. It might be
worthwhile investigating in larger studies whether there
could still be a difference between patients seeking
repeated treatments and other patients.
The fact that mortality in this group was quite high when
compared with the general population is a great challenge
to our society. It is worth emphasizing that not all drug
addicts die early. More research is needed to discover what
makes those patients who survive different from those
who die. This information would be helpful both for
choosing therapy and for identifying those at special risk.
Conclusion
The mortality rate was much higher among opioid addicts
than in the general population, and most deaths were
related to drug dependence. The risk of death was highest
in the first five-year period, but the risk of death remained
high throughout the whole 20-year follow-up period.
There were no differences between those admitted for vol-
untary detoxification and those admitted solely for self-
poisonings. Opioid addiction also seemed to override the
effects of age and gender on mortality.
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